Values First Advisors, Inc. Mirum Pharmaceuticals, Inc. Transaction History
Values First Advisors, Inc.
- $169 Million
- Q1 2024
A detailed history of Values First Advisors, Inc. transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Values First Advisors, Inc. holds 21,408 shares of MIRM stock, worth $737,077. This represents 0.32% of its overall portfolio holdings.
Number of Shares
21,408
Previous 16,740
27.89%
Holding current value
$737,077
Previous $494,000
8.7%
% of portfolio
0.32%
Previous 0.3%
Shares
4 transactions
Others Institutions Holding MIRM
# of Institutions
184Shares Held
54.3MCall Options Held
85KPut Options Held
59.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.5MShares$224 Million8.57% of portfolio
-
Bvf Inc San Francisco, CA4.37MShares$150 Million3.29% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.3MShares$114 Million1.34% of portfolio
-
State Street Corp Boston, MA2.82MShares$97.2 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X02.77MShares$95.3 Million0.04% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.27B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...